Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Differentiating”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchStudy completedNCT00723463
What this trial is testing

Determine if Apparent Diffusion Coefficient (ADC) Values Can Differentiate Tumors From Normal Tissue

Who this might be right for
Brain CancerNeck Cancer
University of Michigan 200
Testing effectiveness (Phase 2)WithdrawnNCT00101140
What this trial is testing

Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia in Remission

Who this might be right for
Adult Acute Erythroid LeukemiaAdult Acute Monoblastic and Acute Monocytic LeukemiaAdult Acute Myeloid Leukemia
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Study completedNCT01788982
What this trial is testing

Nintedanib(BIBF1120) in Thyroid Cancer

Who this might be right for
Medullary Thyroid Cancer (MTC)Differentiated Thyroid Cancer (DTC)
European Organisation for Research and Treatment of Cancer - EORTC 100
Testing effectiveness (Phase 2)Study completedNCT00004217
What this trial is testing

S9918 PSC 833, Daunorubicin, and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Leukemia
SWOG Cancer Research Network 55
Post-approval studies (Phase 4)Ended earlyNCT03065218
What this trial is testing

99mTc Sestamibi Scans In Thyroglobulin Positive Scan Negative Differentiated Thyroid Cancer (DTC) Patients

Who this might be right for
Thyroid Cancer
Medstar Health Research Institute 4
Testing effectiveness (Phase 2)Ended earlyNCT01215578
What this trial is testing

Predictive Biomarkers of Response to Sunitinib in the Treatment of Poorly-differentiated NEURO-Endocrine Tumors

Who this might be right for
Neuroendocrine TumorsPancreatic NeoplasmsAdvanced Disease+1 more
Assistance Publique - Hôpitaux de Paris 33
Not applicableNot Yet RecruitingNCT07153315
What this trial is testing

AI-Based Medical Data Analysis for Differentiating Inflammatory vs Degenerative Joint Diseases in Elderly Patients

Who this might be right for
Arthritis, Rheumatoid (RA)
Assiut University 140
Testing effectiveness (Phase 2)Study completedNCT03870399
What this trial is testing

Study of Tamoxifen in Well Differentiated Neuroendocrine Tumors and Hormone Receptor Positive Expression

Who this might be right for
Neuroendocrine TumorsProgesterone Receptor Positive TumorEstrogen Receptor Positive Tumor
AC Camargo Cancer Center 23
Early research (Phase 1)Study completedNCT02278198
What this trial is testing

Evaluation of Thyroid Stunning From a Diagnostic Dose of I-123

Who this might be right for
Differentiated Thyroid Cancer
University of Colorado, Denver 5
Large-scale testing (Phase 3)Ended earlyNCT00428597
What this trial is testing

Sunitinib Compared To Placebo For Patients With Advanced Pancreatic Islet Cell Tumors

Who this might be right for
Carcinoma, Islet CellCarcinoma, Pancreas
Pfizer 171
Testing effectiveness (Phase 2)WithdrawnNCT03925675
What this trial is testing

18F-Fluciclovine PET and Multiparametric MR Imaging

Who this might be right for
Brain Tumor, Recurrent, Adult
Loma Linda University
Testing effectiveness (Phase 2)Study completedNCT02305810
What this trial is testing

A Biological Prospective Study in Patients With Metastatic Pancreatic NETs Treated With Everolimus

Who this might be right for
Pancreatic Neuroendocrine Tumour Metastatic
European Institute of Oncology 54
Early research (Phase 1)Study completedNCT01031368
What this trial is testing

Clofarabine, Cytarabine, and Filgrastim Followed by Infusion of Non-HLA Matched Ex Vivo Expanded Cord Blood Progenitors in Treating Patients With Acute Myeloid Leukemia

Who this might be right for
Adult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Monoblastic Leukemia (M5a)+15 more
Nohla Therapeutics, Inc. 29
Testing effectiveness (Phase 2)Study completedNCT02132468
What this trial is testing

A Ph 2 Study of Fosbretabulin in Subjects w Pancreatic or Gastrointestinal Neuroendocrine Tumors w Elevated Biomarkers

Who this might be right for
Neuroendocrine Tumors
Mateon Therapeutics 18
Not applicableStudy completedNCT04500925
What this trial is testing

The Incidence of Postoperative Re-stratification for Recurrence in Well-differentiated Thyroid Cancer - A Single Tertiary Israeli Center Experience

Who this might be right for
Well Differentiated Thyroid CarcinomaPapillary Thyroid Cancer
Tel-Aviv Sourasky Medical Center 301
Early research (Phase 1)Active Not RecruitingNCT03170960
What this trial is testing

Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Urothelial CarcinomaRenal Cell CarcinomaNon-Small Cell Lung Cancer+11 more
Exelixis 914
Testing effectiveness (Phase 2)Study completedNCT04321954
What this trial is testing

Lenvatinib in Locally Advanced Invasive Thyroid Cancer

Who this might be right for
Differentiated Thyroid CancerAdvanced Cancer
Massachusetts Eye and Ear Infirmary 29
Not applicableUnknownNCT03169751
What this trial is testing

An Exploratory Trial Using sEMG to Differentiate PNES From Epileptic Seizures

Who this might be right for
Non-Epileptic SeizureMotor SeizureEpilepsy
Brain Sentinel 71
Not applicableUnknownNCT00749697
What this trial is testing

Radioiodine Dosimetry Protocol for Thyroid Cancer Metastases

Who this might be right for
Thyroid CarcinomaMetastatic Sites Lung Bone Nodal
Royal Marsden NHS Foundation Trust 10
Testing effectiveness (Phase 2)Study completedNCT01567488
What this trial is testing

Phase II Study of Everolimus Combined With Octreotide LAR to Treat Advanced GI NET

Who this might be right for
Gastrointestinal Neoplasms
Grupo Espanol de Tumores Neuroendocrinos 43
Next Page